Table 5.
Visit | Chitosan (N = 56) | Placebo (N = 30) | P value between groups |
---|---|---|---|
TG (mg/dl) | |||
Day 0 | 145.2 ± 64.35 | 153.1 ± 76.44 | 0.753 |
Day 45 | 143.7 ± 76.33 | 160.5 ± 92.92 | 0.494 |
Day 90 | 138.8 ± 63.81 | 170.3 ± 102.8 | 0.203 |
HDL(mg/dl) | |||
Day 0 | 41.47 ± 7.50 | 42.87 ± 10.28 | 0.448 |
Day 45 | 44.38 ± 12.01 | 41.14 ± 9.55 | 0.285 |
Day 90 | 43.17 ± 11.65 | 42.08 ± 10.74 | 0.944 |
LDL (mg/dl) | |||
Day 0 | 106.9 ± 27.80 | 107.2 ± 30.39 | 0.959 |
Day 45 | 114.9 ± 42.44* (p = 0.0213) | 113.7 ± 38.66 | 0.746 |
Day 90 | 109.9 ± 31.64 | 115.6 ± 31.93* (p = 0.0266) | 0.428 |
VLDL (mg/dl) | |||
Day 0 | 29.04 ± 12.87 | 30.62 ± 15.29 | 0.746 |
Day 45 | 28.74 ± 15.27 | 32.10 ± 18.59 | 0.494 |
Day 90 | 27.76 ± 12.76 | 34.07 ± 20.55 | 0.203 |
HbA1C (%) | |||
Day 0 | 5.89 ± 0.83 | 5.89 ± 0.75 | 0.912 |
Day 45 | 5.72 ± 0.78* (p = 0.0225) | 5.80 ± 0.68* (p = 0.0419) | 0.661 |
Day 90 | 5.74 ± 0.83* (p = 0.0343) | 5.88 ± 0.57 | 0.138 |
Values are expressed as Mean ± Standard deviation (SD). * = as compared to baseline (Within group comparison). N = Number of patient in each treatment group